Covenant Research and Clinics

Covenant Research and Clinics is a Florida-based clinical research and specialty care organization focused on liver and metabolic disease. The organization appears to operate both as a clinical trial site business under the Covenant Research and Clinics name and as a patient-facing care brand called Covenant Metabolic Specialists. Its activities center on enrolling patients into industry-sponsored trials and providing care for fatty liver disease, metabolic dysfunction-associated steatotic liver disease, steatohepatitis, obesity, diabetes, and related liver conditions. Publicly visible studies linked to the company include trials in primary biliary cholangitis, steatohepatitis, obesity, and liver fibrosis using investigational small-molecule or peptide-based metabolic and hepatology therapies sponsored by larger biopharma companies. The company is not a drug developer with an internal proprietary pipeline; rather, it functions primarily as a healthcare and clinical research operator with multiple Florida locations and investigator-led site capabilities.